TipRanks
Advertisement
Advertisement

ANRO Stock Latest News

Alto Neuroscience price target raised to $60 from $55 at H.C. Wainwright
The FlyAlto Neuroscience price target raised to $60 from $55 at H.C. Wainwright
22h ago
ANRO
Alto Neuroscience (ANRO) Defendants Move to Dismiss Third Amended Securities Complaint Over Phase 2b Trial Disclosures
PremiumClass Action
Alto Neuroscience (ANRO) Defendants Move to Dismiss Third Amended Securities Complaint Over Phase 2b Trial Disclosures
27d ago
ANRO
Alto Neuroscience Promotes Smith to President, CFO
PremiumCompany Announcements
Alto Neuroscience Promotes Smith to President, CFO
2M ago
8K
ANRO
Alto Neuroscience names Nick Smith president, CFO
PremiumThe Fly
Alto Neuroscience names Nick Smith president, CFO
2M ago
ANRO
Alto Neuroscience Lawsuit Dismissed for Now, With Investors Given Chance to Amend Claims
PremiumClass Action
Alto Neuroscience Lawsuit Dismissed for Now, With Investors Given Chance to Amend Claims
2M ago
ANRO
Alto Neuroscience price target raised to $55 from $50 at H.C. Wainwright
PremiumThe FlyAlto Neuroscience price target raised to $55 from $50 at H.C. Wainwright
2M ago
ANRO
Alto Neuroscience reports Q EPS (65c), consensus (77c)
Premium
The Fly
Alto Neuroscience reports Q EPS (65c), consensus (77c)
2M ago
ANRO
Alto Neuroscience price target raised to $37 from $28 at BTIG
Premium
The Fly
Alto Neuroscience price target raised to $37 from $28 at BTIG
2M ago
ANRO
Alto Neuroscience price target raised to $37 from $33 at BofA
PremiumThe Fly
Alto Neuroscience price target raised to $37 from $33 at BofA
2M ago
ANRO
Analyst Lifts ALTO-207 Price Target to $37 on Strong TRD Profile and Expanded Monotherapy Strategy, Reiterates Buy
PremiumRatings
Analyst Lifts ALTO-207 Price Target to $37 on Strong TRD Profile and Expanded Monotherapy Strategy, Reiterates Buy
2M ago
ANRO
Alto Neuroscience Raises Capital to Advance ALTO-207
PremiumCompany Announcements
Alto Neuroscience Raises Capital to Advance ALTO-207
3M ago
8K
ANRO
Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 Trials
PremiumCompany Announcements
Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 Trials
3M ago
8K
ANRO
Alto Neuroscience prices 3.78M shares at $26.48 in registered direct offering
PremiumThe FlyAlto Neuroscience prices 3.78M shares at $26.48 in registered direct offering
3M ago
ANRO
Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol
Premium
The Fly
Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol
4M ago
ANRO
Alto Neuroscience Appoints Andrew Miller to Board
Premium
Company Announcements
Alto Neuroscience Appoints Andrew Miller to Board
5M ago
8K
ANRO
Alto Neuroscience appoints Miller to Board of Directors
PremiumThe Fly
Alto Neuroscience appoints Miller to Board of Directors
5M ago
ANRO
Alto Neuroscience Buy Rating Reiterated as Analyst Highlights De-Risked Pipeline, Strong Cash Runway and Maintains $50 Price Target
PremiumRatings
Alto Neuroscience Buy Rating Reiterated as Analyst Highlights De-Risked Pipeline, Strong Cash Runway and Maintains $50 Price Target
5M ago
ANRO
Alto Neuroscience price target lowered to $33 from $35 at BofA
PremiumThe Fly
Alto Neuroscience price target lowered to $33 from $35 at BofA
5M ago
ANRO
Alto Neuroscience price target lowered to $36 from $38 at Baird
PremiumThe Fly
Alto Neuroscience price target lowered to $36 from $38 at Baird
5M ago
ANRO
Alto Neuroscience price target raised to $24 from $21 at Wedbush
PremiumThe FlyAlto Neuroscience price target raised to $24 from $21 at Wedbush
5M ago
ANRO
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
Premium
Ratings
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
5M ago
ANRO
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
Premium
Ratings
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
5M ago
ANRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >